SCHEMBL14048484

SCHEMBL14048484

COC(=O)Cc1ccc(Nc2ccc(OC)c3ccccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 4/20 0.55
FABP4 P15090 1/20 0.51
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.47
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
KDM4E B2RXH2 1/20 0.45
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
PLK1 P53350 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
HPGDS O60760 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14048633 0.85 CDC25B (0.59) CDC25BFABP4ALDH1A1KMT2AMEN1
SCHEMBL14048607 0.81 RAB9A (0.58) CDC25BALDH1A1HPGDKMT2AMEN1
SCHEMBL4594364 0.80 CDC25B (0.62) CDC25BFABP4KMT2AMEN1KDM4E
SCHEMBL4593706 0.80 CDC25B (0.74) CDC25BFABP4KMT2AMEN1
SCHEMBL27580499 0.80 RAB9A (0.50) CDC25BALDH1A1HPGDKMT2AMEN1
SCHEMBL4594920 0.78 CDC25B (0.67) CDC25BALDH1A1HPGDKMT2AMEN1
SCHEMBL4594590 0.77 RAB9A (0.64) CDC25BALDH1A1HPGDKMT2AMEN1
SCHEMBL31324197 0.77 HPGD (0.58) ALDH1A1HPGDKMT2AKDM4ECYP4F2
SCHEMBL1407839 0.75 MAPT (0.55) ALDH1A1HPGDKMT2AMEN1KDM4E
SCHEMBL14030692 0.75 CDC25B (0.63) CDC25BFABP4HPGDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255232-A1 Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation APP, BACE1, SNCA CDC25B 2914/4885FABP4 2180/4885ALDH1A1 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.